Not to Miss: Intronic Variants, Treatment, and Review of the Phenotypic Spectrum in VPS13D-Related Disorder

Int J Mol Sci. 2023 Jan 18;24(3):1874. doi: 10.3390/ijms24031874.

Abstract

VPS13D is one of four human homologs of the vacuolar sorting protein 13 gene (VPS13). Biallelic pathogenic variants in the gene are associated with spastic ataxia or spastic paraplegia. Here, we report two patients with intronic pathogenic variants: one patient with early onset severe spastic ataxia and debilitating tremor, which is compound-heterozygous for a canonical (NM_018156.4: c.2237-1G > A) and a non-canonical (NM_018156.4: c.941+3G>A) splice site variant. The second patient carries the same non-canonical splice site variant in the homozygous state and is affected by late-onset spastic paraplegia. We confirmed altered splicing as a result of the intronic variants and demonstrated disturbed mitochondrial integrity. Notably, tremor in the first patient improved significantly by bilateral deep brain stimulation (DBS) in the ventralis intermedius (VIM) nucleus of the thalamus. We also conducted a literature review and summarized the phenotypical spectrum of reported VPS13D-related disorders. Our study underscores that looking for mutations outside the canonical splice sites is important not to miss a genetic diagnosis, especially in disorders with a highly heterogeneous presentation without specific red flags.

Keywords: VPS13D; deep brain stimulation; spastic ataxia.

Publication types

  • Review

MeSH terms

  • Humans
  • Intellectual Disability
  • Muscle Spasticity
  • Mutation
  • Optic Atrophy
  • Paraplegia
  • Pedigree
  • Proteins / genetics
  • Spastic Paraplegia, Hereditary* / genetics
  • Spinocerebellar Ataxias
  • Tremor

Substances

  • Proteins
  • VPS13D protein, human

Supplementary concepts

  • Spastic Ataxia